Novavax (NVAX) earnings, Nov 5, 2026: EPS +85%, stock −8.2%
In brief
Novavax reported on Nov 5, 2026. Earnings per share changed +85% year over year, 45.1% above the estimate; revenue −3%. The stock opened with a −2.9% gap and closed the day −8.2% (Nov 5, 2026). The stock is now 26.9% below its 52-week high, +27.2% over 12 months.
EPS vs estimate+45.1%
EPS, YoY+85%
Revenue, YoY−3%
Gap · day−2.9% · −8.2%
EPS growth by quarter, YoY
Price reaction to earnings
| Report | Gap | Day |
|---|---|---|
| Aug 6, 2026 | +1.6% | +0.5% |
| Nov 5, 2026 | −2.9% | −8.2% |
Next-quarter estimates, ratings and the NVAX chart are in the terminal.
Open the terminalFAQ
When is Novavax's next earnings report?
There is no new date in the data yet: companies announce it a few weeks ahead.
How did Novavax stock react to the report?
Opening gap −2.9%, day's result −8.2%.
Did Novavax's earnings grow?
Earnings per share rose 85% year over year.
What is an earnings gap?
The jump between the close before and the open after the report. A big gap up often means large buyers are revaluing the company.